Gene · 4741
Papers1,719
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,719
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurofilaments in health and Charcot-Marie-Tooth disease. | Front Cell Dev Biol | 2023 | 38164457 | PubTator, text mining | PubMed |
| Severe central nervous system demyelination in Sanfilippo disease. | Front Mol Neurosci | 2023 | 38163061 | PubTator, text mining | PubMed |
| Effectiveness of pharmacogenomics on the response and remission of treatment-resistant depression: a meta-analysis of randomised controlled trials. | Gen Psychiatr | 2023 | 38155841 | PubTator, text mining | PubMed |
| Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis. | Antibodies (Basel) | 2023 | 38131803 | PubTator, text mining | PubMed |
| Shedding light on neurofilament involvement in cognitive decline in obstructive sleep apnea and its possible role as a biomarker. | Front Psychiatry | 2023 | 38098628 | PubTator, text mining | PubMed |
| Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness. | Alzheimers Dement (Amst) | 2023 | 38094990 | PubTator, text mining | PubMed |
| The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I. | Front Immunol | 2023 | 38077397 | PubTator, text mining | PubMed |
| Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status. | Front Neurol | 2023 | 38073633 | PubTator, text mining | PubMed |
| Serum amyloid P component accumulates and persists in neurones following traumatic brain injury. | Open Biol | 2023 | 38052249 | PubTator, text mining | PubMed |
| Biomarkers and experimental models for cancer immunology investigation. | MedComm (2020) | 2023 | 38045830 | PubTator, text mining | PubMed |
| Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era. | Front Neurol | 2023 | 38020652 | PubTator, text mining | PubMed |
| Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases. | J Alzheimers Dis | 2023 | 38007650 | PubTator, text mining | PubMed |
| Identifying the Phenotypes of Diffuse Axonal Injury Following Traumatic Brain Injury. | Brain Sci | 2023 | 38002566 | PubTator, text mining | PubMed |
| Differential Expression of MicroRNA (MiR-27, MiR-145) among Dental Pulp Stem Cells (DPSCs) Following Neurogenic Differentiation Stimuli. | Biomedicines | 2023 | 38002003 | PubTator, text mining | PubMed |
| Neuroinflammation in the Evolution of Motor Function in Stroke and Trauma Patients: Treatment and Potential Biomarkers. | Curr Issues Mol Biol | 2023 | 37998716 | PubTator, text mining | PubMed |
| The Comparison of the Selected Parameters of Brain Injury and Interleukins in the CSF in Patients Diagnosed De Novo with RRMS Compared to the Control Group. | Diagnostics (Basel) | 2023 | 37998571 | PubTator, text mining | PubMed |
| Single-cell epigenomics and spatiotemporal transcriptomics reveal human cerebellar development. | Nat Commun | 2023 | 37993461 | PubTator, text mining | PubMed |
| Altered plasma protein profiles in genetic FTD - a GENFI study. | Mol Neurodegener | 2023 | 37968725 | PubTator, text mining | PubMed |
| Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions. | Front Mol Neurosci | 2023 | 37965041 | PubTator, text mining | PubMed |
| ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity. | Int J Mol Sci | 2023 | 37958729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4741/papers?page=4